The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Navolockaya V.K.

Moscow State University of Medicine and Dentistry named after A.I.Evdokimov, Moscow, Russian Federation

Liashko E.S.

Kafedra reproduktivnoĭ meditsiny i khirurgii FPDO Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta im. A.I. Evdokimova;
Gorodskaia klinicheskaia bol'nitsa #15 im. O.M. Filatova;
Kafedra anesteziologii i reanimatologii FPK MR Rossiĭskogo universiteta druzhby narodov, Moskva

Shifman E.M.

M.F. Vladimirsky Moscow Regional Research Clinical Institute, Ministry of Health of the Moscow Region, Moscow, Russia

Konysheva O.V.

Filatov City Clinical Hospital №15, Moscow, Russia

Kulikov A.V.

Arustamian R.R.

Kafedra reproduktivnoĭ meditsiny i khirurgii FPDO Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta im. A.I. Evdokimova;
Gorodskaia klinicheskaia bol'nitsa #15 im. O.M. Filatova;
Kafedra anesteziologii i reanimatologii FPK MR Rossiĭskogo universiteta druzhby narodov, Moskva

Pylaeva N.Yu.

Medical Academy named after S. I. Georgievsky of V. I. Vernadsky Crimean Federal University, Department of anesthesiology-resuscitaion and emergency medicine Simferopol, Russian Federation

Possibilities for prediction of preeclampsia complications (a review)

Authors:

Navolockaya V.K., Liashko E.S., Shifman E.M., Konysheva O.V., Kulikov A.V., Arustamian R.R., Pylaeva N.Yu.

More about the authors

Journal: Russian Journal of Human Reproduction. 2019;25(1): 87‑96

Read: 1469 times


To cite this article:

Navolockaya VK, Liashko ES, Shifman EM, Konysheva OV, Kulikov AV, Arustamian RR, Pylaeva NYu. Possibilities for prediction of preeclampsia complications (a review). Russian Journal of Human Reproduction. 2019;25(1):87‑96. (In Russ.)
https://doi.org/10.17116/repro20192501187

Recommended articles:
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79
Effe­ctiveness of using preventive and personalized technologies for obesity correction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):80-90
Predictors of myocardial infa­rction in patients with stable peri­pheral artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):61-65
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10
Dyna­mics of arte­rial stiffness indi­cators during anti­hypertensive therapy. Russian Journal of Preventive Medi­cine. 2025;(2):74-79

References:

  1. Yi HY, Jeong SY, Kim SH, Kim Y, Choi SJ, Oh SY, Roh CR, Kim JH. Indications and characteristics of obstetric patients admitted to theintensive care unit: a 22-year review in a tertiary care center. Obstetrics and Gynecology Science. 2018;61(2):209-219. https://doi.org/10.5468/ogs.2018.61.2.209
  2. Katsuragi S, Tanaka H, Hasegawa J, Nakamura M, Kanayama N, Nakata M, Murakoshi T, Yoshimatsu J, Osato K, Tanaka K, Sekizawa A, Ishiwata I, Ikeda T. On behalf of the Maternal Death Exploratory Committee in Japan and Japan Association of Obstetricians and Gynecologists. Analysis of preventability of hypertensive disorder in pregnancy-related maternal death using the nationwide registration system of maternal deaths in Japan. Journal of Maternal-Fetal and Neonatal Medicine. 2018;31(16):2097-2104. https://doi.org/10.1080/14767058.2017.1336222
  3. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Seminars in Perinatology. 2012;36(1):56-59. https://doi.org/10.1053/j.semperi.2011.09.011
  4. Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstetrics and Gynecology. 2014;124(4):771-781. https://doi.org/10.1097/AOG.0000000000000472
  5. Gupta AK. Hypertensive disorders in pregnancy and the risk of cardiovascular disease: a need for postpartum strategies for the primary prevention. Journal of American Heart Association. 2018;7:e009648. https://doi.org/10.1161/JAHA.118.009648
  6. Panaitescu AM, Baschat AA, Akolekar R, Syngelaki A, Nicolaides KH. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound in Obstetrics and Gynecology. 2017;50(3):361-366. https://doi.org/10.1002/uog.17553
  7. Khodzhaeva ZS, Kholin AM, Vikhlyaeva EM. Early and late preeclampsia: a paradigm pathobiology and clinical practice. Akusherstvo i ginekologiya. 2013;10:4-11. (In Russ.)
  8. Vodneva DN, Romanova VV, Dubova EA, Pavlov KA, Shmakov RG, Shchegolev AI. The clinical and morphological features of early- and late-onset preeclampsia. Akusherstvo i ginekologiya. 2014;2:35-40. (In Russ.)
  9. Khodjaeva ZS, Akateva AS, Kholin AM, Safonova AD, Vavina OV, Muminova KT. Molecular determinants of early and late preeclampsia. Akusherstvo i ginekologiya. 2014;6:14-19. (In Russ.)
  10. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2011;52(5):873-880. https://doi.org/10.1161/HYPERTENSIONAHA.108.117358
  11. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology. 2011;204(3):193-201. https://doi.org/10.1016/j.ajog.2010.08.009
  12. Ivanets TYu, Alekseeva ML, Goncharova EA, Khodzhaeva ZS, Vavina OV. Preeclampsia markers in I and II trimesters of pregnancy. Problemy reproduktsii. 2012;3:83-87. (In Russ.)
  13. Perni U, Cristina Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, August Ph. Angiogenic factors in superimposed preeclampsia. A longitudinal study of women with chronic hypertension during pregnancy. Hypertension. 2012;59:740-746. https://doi.org/10.1161/hypertensionaha.111.181735
  14. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal. 2011;330:565-575. https://doi.org/10.1136/bmj.38380.674340.E0
  15. Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000 Faculty Reviews. 2018;2:242. https://doi.org/10.12688/f1000research.12249.1
  16. Ukah UV, De Silva DA, Payne B, Magee LA, Hutcheon JA, Brown H, Ansermino JM, Lee T, von Dadelszen P. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertension. 2018;11:115-123. https://doi.org/10.1016/j.preghy.2017.11.006
  17. Ivanets TYu, Alekseyeva ML, Loginova NS, Kolodko VG, Nasonova DM, Khasiyanova ZSh. The placental growth factor and fmssimilar tyrosine kinase-1 asmarkers of preeclampsy. Klinicheskaya laboratornaya diagnostica. 2013;8:14-17. (In Russ.)
  18. Starodubtseva NL, Popov IA, Nikolayev EN, Ivanets TYu, Alekseyeva ML, Loginova NS, Nikolaeva AV, Vavina OV, Sukhikh GT. Search for reproducible biomarkers for the diagnosis of preeclmpsia. Akusherstvo i ginekologiya. 2013;2:10-17. (In Russ.)
  19. Sidorova IS, Nikitina NA. Features of the pathogenesis of endotheliosis inpreeclampsia. Akusherstvo i ginekologiya. 2015;1:72-78. (In Russ.)
  20. Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. Journal of the American Society of Hypertension. 2012;6(2):85-99. https://doi.org/10.1016/j.jash.2011.11.003
  21. Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. American Journal of Obstetrics and Gynecology. 2005;192(3):734-741. https://doi.org/10.1016/j.ajog.2004.12.052
  22. Yildirim ZK, Sumnu A, Bademler N, Kilic E, Sumnu G, Karadag S, Gursu M, Ozel A, Batmaz G, Ates S, Dane B, Ozturk S. Soluble TNF-like weak inducer of apoptosis as a new marker in preeclampsia: a pilot clinical study. Disease Markers. 2016;2016:5930589. https://doi.org/10.1155/2016/5930589
  23. Sharma K, Singh R, Kumar M, Gupta U, Rohil V, Bhattacharjee J. First-trimester inflammatory markers for risk evaluation of pregnancy hypertension. Journal of Obstetrics and Gynaecology of India. 2018;68(1):27-32. https://doi.org/10.1007/s13224-017-0988-1
  24. Gupta M, Feinbergb BB, Burwicka RM.Thrombotic microangiopathies of pregnancy: Differential diagnosis. Pregnancy Hypertension. 2018;12:29-34. https://doi.org/10.1016/j.preghy.2018.02.007
  25. Sun F, Qian W, ZhangCh, Fan J-X, Huang H-F. Correlation of maternal serum homocysteine in the first trimester with the development of gestational hypertension and preeclampsia. Medical Science Monitor. 2017;23:5396-5401. https://doi.org/10.12659/msm.905055
  26. Grebennik TK, Pavlovich SV. The possibilities of prediction of preeclampsia. Akusherstvo i ginekologiya. 2011;6:4-6. (In Russ.)
  27. Park J, Cha DH, Lee SJ, Kim YN, Kim YH, Kim KP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Experimental and Molecular Medicine. 2011;43(7):427-435. https://doi.org/10.3858/emm.2011.43.7.047
  28. Liu C, Zhang N, Yu H, Chen Y, Liang Y, Deng H, Zhang Z. Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta. 2011;32(2):168-174. https://doi.org/10.1016/j.placenta.2010.11.007
  29. Sachan R, Patel ML, Dhiman S, Gupta P, Sachan P, Shyam R. Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia. Advanced Biomedicai Research. 2016;5:119. https://doi.org/10.4103/2277-9175.18699
  30. Muminova KT, Vavina OV, Polushkina ES, Ivanets TYu, Bezzubenko YuV, Strokova SO, Shmakov RG, Khodzhaeva ZS. Search for new markers for preeclampsia. Akusherstvo i ginekologiya. 2016;7:41-45. (In Russ.) https://doi.org/10.18565/aig.2016.7.41-45
  31. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound in Obstetrics and Gynecology. 2006;27(1):13-17. https://doi.org/10.1002/uog.2686
  32. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 to 24 weeks’ gestation. Ultrasound in Obstetrics and Gynecology. 2006;27:658-663. https://doi.org/10.1002/uog.2676
  33. Rocha-Penha L, Caldeira-Dias M, Tanus-Santos JE, Carvalho Cavalli R, Sandrim VC. Myeloperoxidase in hypertensive disorders of pregnancy and its relation with nitric oxide. Hypertension. 2017;69:1173-1180. https://doi.org/10.1161/hypertensionaha.116.08854
  34. Molvarec A, Ibolya C, János S, János R. Increased circulating interleukin-17 levels in preeclampsia. Journal of Reproductive Immunology. 2015;112:53-57. https://doi.org/10.1016/j.jri.2015.05.007
  35. Indira A-F, Prieto B, Rodríguez V, Ruano Y, Escudero AI, Álvarez FV. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clinica Chimica Acta. 2016;463:150-157. https://doi.org/10.1016/j.cca.2016.10.033
  36. Giannubilo SR, CecchiS, Tidu E, CiavattiniA. Maternal NT-proBNP in chronic hypertensive pregnancies and superimposed preeclampsia. International Journal of Cardiology. 2014;176(3):1227-1229. https://doi.org/10.1016/j.ijcard.2014.07.214
  37. Matya LR, Skubas NJ, Shernan SK, Mahmood F. Perioperative assessment of diastolic dysfunction. Anesthesia and Analgesia. 2011;113:449-472. https://doi.org/10.1213/ane.0b013e31822649ac
  38. Afshani N, Dyer RA, Moustaqim-Barrette A, Biccar BM, Rodseth RN. Utility of B-type natriuretic peptides in preeclampsia: a systematic review. International Journal of Obstetric Anesthesia. 2013;22(2):96-103. https://doi.org/10.1097/01.aoa.0000446286.45372.d1
  39. Burlev AV, Burlev VA, Il’iasova NA, Shifman EM. Oxidative stress in perioperative period of cesarean section. Anesteziologiya i reanimatologiya. 2014;59(6):23-28. (In Russ.)
  40. Merkusheva LI, Kozlovskaya NL. Current ideas on the pathogenesis of renal injury in preeclampsia. Akusherstvo. 2015;8:12-17. (In Russ.)
  41. Mukhin NA. Nefrologija. Nacional’noe rukovodstvo. M.: GEHOTAR-Media; 2016. (In Russ.)
  42. Treviño-Becerra A. Uric Acid: The unknown uremic toxin. Contributions to Nephrology. 2018;192:25-33. https://doi.org/10.1159/000484275
  43. Brien ME, Duval C, Palacios J, Boufaied I, Hudon-Thibeault AA, Nadeau-Vallée M, Vaillancourt C, Sibley CP, Abrahams VM, Jones RL, Girard S. Uric acid crystals induce placental inflammation and alter trophoblast function via an il-1-dependent pathway: implications for fetal growth restriction. Journal of Immunology. 2017;198(1):443-451. https://doi.org/10.4049/jimmunol.1601179
  44. Stodle GS, Silva GB, Tangeras LH, Gierman LM, Nervik I, Dahlberg UE, Sun C, Aune MH, Thomsen LCV, Bjorge L, Iversen AC. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clinical and Experimental Immunology. 2018;193(1):84-94. https://doi.org/10.1111/cei.13130
  45. Moreno Santillan AA, Briones Garduno JC, Diaz de Leon Ponce MA.Uric Acid in Pregnancy: New Concepts. Contributions to Nephrology. 2018;192:110-115. https://doi.org/10.1159/000484285
  46. Navolotskaya VK, Lyashko ES, Shifman EM, Kulikov AV, Arustamyan RR, Pylaeva NYu. Uric acid is the «new» old marker of preeclampsia and its complications (review of the literature). Problemy reproduktsii. 2018;24(4):94-101. (In Russ.)
  47. Burlev AV, Burlev VA, Ilyasova NA, Sokologorsky SV, Shifman EM. Angiogenic growth factors in the ceresbropinal liquid of pregnant women during plannedcesarean section under combined spinal-epidural anaesthesia. Anesteziologiya i reanimatologiya. 2012;6:39-44. (In Russ.)
  48. Burlev AV, Burlev VA, Shifman EM, Ilyasova NA, Sukhikh GT. Target effects ofangiogenic and inflammatory stress in patients during perioperative regional and general anesthesia for elective cesarean section. Akusherstvo i ginekologiya. 2012;8(2):33-41. (In Russ.)
  49. Starodubceva NL, Bugrova AE, Kononikhin AS, Vavina OV, Shirokova VA, Naumov VA, Garanina IA, Lagutin VV, Popov IA, Loginova NS, Hodzhaeva ZS, Frankevich VE, Nikolaev EN, Sukhikh GT. The ability to predict and early diagnose of preeclampsia on the peptide profile of urine. Akusherstvo I ginekologiya. 2015;6:46-52. (In Russ.)
  50. Niraula A, Lamsal M, Baral N, MajhiSh, Ahmed Khan S, Basnet P, Dahal K. Cystatin-C as a marker for renal impairment in preeclampsia. Journal of Biomarkers. 2017;2017:7406959. https://doi.org/10.1155/2017/7406959
  51. Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. Journal of Pregnancy. 2012;2012:586578. https://doi.org/10.1155/2012/586578.586578
  52. Sumithra K, Vibha C, Vishwanath H L. Study of Serum cystatin C in Preeclampsia. International Journal of Current Research. 2013;5(10):2994-2996.
  53. Lamb EJ, Price CP. Kidney Function Tests. Teitz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th. Philadelphia, Pa, USA: Elsevier Publishers; 2013:669-707.
  54. Guo H-X, Wang C-H, Li Z-Q, Gong S-P, Zhou Z-Q, Leng L-Z, Zhong M. The application of serum cystatin C in estimating the renal function in women with preeclampsia. Reproductive Sciences. 2012;19(7):712-717. https://doi.org/10.1177/1933719111431001
  55. Risch M, Purde M-T, Baumann M, Mohaupt M,Mosimann B, Renz H, Raio L, Surbek D, Risch L. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scandinavian Journal of Clinical and Laboratory Investigation. 2017;77(8):634-643. https://doi.org/10.1080/00365513.2017.1393692

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.